Skip to main content

Patrick Aloy: "Alzheimer's needs to be tackled from a global perspective"

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Interview in El Mundo with Patrick Aloy, ICREA researcher at IRB Barcelona, about a 5-year study on Alzheimer’s disease that he will undertake through a project awarded funding from the European Research Council.

In the one-page interview, Aloy explains at length the problem encountered when dealing with Alzheimer’s and how his lab plans to tackle it in order to monitor the onset and progression of this condition and to discover new therapeutic targets.

Read the interview in El Mundo - Cultural (PDF)

Related news:

14 January 2014
IRB receives 1.3 M€ from the European Research Council for investigation into Alzheimer’s disease

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).